← Back to Search

Walnut Intake for Cardiovascular Risk

N/A
Waitlist Available
Led By Roberta R Holt, PhD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 weeks
Awards & highlights

Study Summary

This trial will enroll postmenopausal women who are at risk for cardiovascular disease due to their menopausal status and increased central adiposity. The study will assess the 12 week influence of 40 g of daily walnut intake on the health of overweight and obese postmenopausal women.

Eligible Conditions
  • Cardiovascular Risk
  • Endothelial Dysfunction
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Framingham Reactive Hyperemia Index (fRHI)
Reactive Hyperemia Index (RHI)
Secondary outcome measures
ADP-Induced Platelet Aggregation
Collagen-Induced Platelet Aggregation
Ellagitannin Metabolites
+7 more
Other outcome measures
Blood Pressure
Complete Blood Cell Count
Complete Metabolic Panel
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Walnut IntakeExperimental Treatment1 Intervention
Experimental Arm of 12 weeks of Walnut Intake, with study visits at baseline (prior to walnut intake) and after 6 and 12 weeks of 40g of Walnut Intake.
Group II: Habitual IntakeActive Control1 Intervention
This will be the comparative arm, of 6 weeks before and after the study participant is on their habitual diet

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
910 Previous Clinical Trials
4,706,971 Total Patients Enrolled
4 Trials studying Cardiovascular Risk
166 Patients Enrolled for Cardiovascular Risk
Roberta R Holt, PhDPrincipal InvestigatorUniversity of California, Davis
1 Previous Clinical Trials
9 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical trial accept participants below the age of 40?

"This study has a restricted age range of 45-65 years. 61 clinical trials are available for participants below the legal age, while 298 studies target those over 65."

Answered by AI

How many participants are being accepted into this research project?

"Indeed, clinicaltrials.gov data affirms that this investigation is recruiting patients at present. This study was initially announced on September 1st 2019 and most recently updated on January 26th 2022. Approximately 20 subjects are sought from one medical site."

Answered by AI

Are researchers still recruiting participants for this trial?

"According to clinicaltrials.gov, this study is currently in need of volunteers; it was posted on September 1st 2019 and last revised on January 26th 2022."

Answered by AI

What key insights are researchers hoping to gain from this exploration?

"The main outcome measure of this 18-week trial is the Reactive Hyperemia Index (RHI). Supplementary objectives include measuring Plasma Fatty Acids, Ellagitannin Metabolites and Urolithin Metabolites."

Answered by AI

Who are the ideal candidates to enroll in this clinical research endeavor?

"This trial seeks 20 participants with cardiovascular risk that are between 45 and 65 years old. Women must be post-menopausal for at least two years, have a BMI of 25-35 kg/m2, and agree to comply with the study protocols in order to qualify."

Answered by AI

Who else is applying?

What state do they live in?
California
What site did they apply to?
Department of Nutrition
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
0
Recent research and studies
clinicaltrials.govStudy
Influence of Walnut Intake on Vascular Function and Metabolism
2019. "Influence of Walnut Intake on Vascular Function and Metabolism". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03900403.
~4 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top